Emphysema in COPD: consequences and causes

Editorial

G M Turino. Thorax. 2006 Dec.

. 2006 Dec;61(12):1031-2.

doi: 10.1136/thx.2006.066308.

Abstract

There is still much to be learned about the cellular and cytokine reactions of specific phenotypes in COPD

Competing interests: none declared.

Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, Papi A, Palladini G, Luisetti M, Annovazzi L, Iadarola P, De Rosa E, Fabbri LM, Mapp CE. Boschetto P, et al. Thorax. 2006 Dec;61(12):1037-42. doi: 10.1136/thx.2006.058321. Epub 2006 Jun 12. Thorax. 2006. PMID: 16769715 Free PMC article.

1. Pauwels R A, Buist A S, Calverley P M.et al Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 20011631256–1276. - PubMed
1. Cello B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 200423932–946. - PubMed
1. Boschetto P, Quintavalle S, Zeni E.et al Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006611037–1042. - PMC - PubMed
1. Celli B R, Cote C G, Marin J M.et al The body‐mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 20043501005–1012. - PubMed
1. Boschetto P, Miniati M, Miotto D.et al Emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 200321450–454. - PubMed